Biotinidase deficiency

Content coming soon

Latest

My journey to an ataxia diagnosis

Ataxia is so rare that it can take years for people to receive a correct diagnosis. David shares his journey here.
Toxic protein production reduced in SCA3 and SCA1 by genetic approach

Spinocerebellar ataxia type 3 (SCA3) and type 1 (SCA1) are caused by mutations in the Ataxin-3 and Ataxin-1 genes that. Researchers recently tested out a type of therapy that works by targeting these genes.
The Edgson family: Kathy, Kizzy and the pets

Kathy has cerebellar ataxia and her daughter, Kizzy, is her carer. Together, they have started a blog to share their outings and tips with you.
Ataxia UK funds new FA research project developing new FA animal models to test gene therapy

Ataxia UK is funding a new project led by Dr Filip Lim’s research group that builds upon their previous research into a gene therapy for Friedreich’s ataxia.